Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 21;6(12):e41735.
doi: 10.2196/41735.

Two-way Automated Text Messaging Support From Community Pharmacies for Medication Taking in Multiple Long-term Conditions: Human-Centered Design With Nominal Group Technique Development Study

Affiliations

Two-way Automated Text Messaging Support From Community Pharmacies for Medication Taking in Multiple Long-term Conditions: Human-Centered Design With Nominal Group Technique Development Study

Gemma Donovan et al. JMIR Form Res. .

Abstract

Background: Reviews of digital communication technologies suggest that they can be effective in supporting medication use; however, their use alongside nondigital components is unclear. We also explored the delivery of a digital communication intervention in a relatively novel setting of community pharmacies and how such an intervention might be delivered to patients with multiple long-term conditions. This meant that despite the large number of intervention examples available in the literature, design questions remained, which we wanted to explore with key stakeholders. Examples of how to involve stakeholders in the design of complex health care interventions are lacking; however, human-centered design (HCD) has been suggested as a potential approach.

Objective: This study aimed to design a new community pharmacy text messaging intervention to support medication use for multiple long-term conditions, with patient and health care professional stakeholders in primary care.

Methods: HCD was used to map the intervention "journey" and identify design questions to explore with patients and health care professionals. Six prototypes were developed to communicate the intervention concept, and a modified version of the Nominal Group Technique was used to gather feedback. Nominal group meetings generated qualitative data using questions about the aspects that participants liked for each prototype and any suggested changes. The discussion was analyzed using a framework approach to transform feedback into statements. These statements were then ranked using a web-based questionnaire to establish a consensus about what elements of the design were valued by stakeholders and what changes to the design were most important.

Results: A total of 30 participants provided feedback on the intervention design concept over 5 nominal group meetings (21 health care professionals and 9 patients) with a 57% (17/30) response rate to the ranking questionnaire. Furthermore, 51 proposed changes in the intervention were generated from the framework analysis. Of these 51 changes, 27 (53%) were incorporated into the next design stage, focusing on changes that were ranked highest. These included suggestions for how text message content might be tailored, patient information materials, and the structure for pharmacist consultation. All aspects that the participants liked were retained in the future design and provided evidence that the proposed intervention concept had good acceptability.

Conclusions: HCD incorporating the Nominal Group Technique is an appropriate and successful approach for obtaining feedback from key stakeholders as part of an iterative design process. This was particularly helpful for our intervention, which combined digital and nondigital components for delivery in the novel setting of a community pharmacy. This approach enabled the collection and prioritization of useful multiperspective feedback to inform further development and testing of our intervention. This model has the potential to minimize research waste by gathering feedback early in the complex intervention design process.

Keywords: community pharmacy; complex interventions; human-centered design; medication adherence; text messaging.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: GD is employed by Generated Health, the company which owns and operate Florence Intelligent Health Messaging software; however, this work was undertaken before her employment. Generated Health have not influenced the design, data collection, analysis, interpretation, or write-up of this publication.

Figures

Figure 1
Figure 1
Program theory for how the new intervention combining 2-way automated text messaging delivered from a community pharmacy would work to support medication taking.
Figure 2
Figure 2
Patient “Journey Map” for the proposed intervention combining automated 2-way text messaging and community pharmacy support.

Similar articles

Cited by

References

    1. Organisation mondiale de la santé, World Health Organization . Adherence to Long-term Therapies Evidence for Action. Geneva: World Health Organization; 2003.
    1. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 21;8(1):e016982. doi: 10.1136/bmjopen-2017-016982. https://bmjopen.bmj.com/lookup/pmidlookup?view=long&pmid=29358417 bmjopen-2017-016982 - DOI - PMC - PubMed
    1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012 Jul 07;380(9836):37–43. doi: 10.1016/S0140-6736(12)60240-2. https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(12)60240-2 S0140-6736(12)60240-2 - DOI - PubMed
    1. Vetrano DL, Bianchini E, Onder G, Cricelli I, Cricelli C, Bernabei R, Bettoncelli G, Lapi F. Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy. Geriatr Gerontol Int. 2017 Dec 28;17(12):2500–6. doi: 10.1111/ggi.13115. - DOI - PubMed
    1. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011. doi: 10.1002/14651858.CD000011.pub4. https://europepmc.org/abstract/MED/25412402 - DOI - PMC - PubMed

LinkOut - more resources